During 2019–2020, SBU is one of several participants in the coreASTHMA project ). The project is led by the Green Park Collaborative (GPC) and Allergy & Asthma Network.
The goal of the coreASTHMA-project is to develop a core outcome set for pivotal or late phase clinical trials of therapies for moderate to severe asthma. Participants are patients, clinicians, researchers, payers, industry, regulatory agencies and health technology assessment agencies.